Heron Therapeutics
HRTX • NASDAQ • Stock Fundamentals
Heron Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Craig Alexander Collard, with a market cap of $76.8M.
Market Cap$76.8M
Employees126.0
CEOCraig Alexander Collard
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Heron Therapeutics FAQ
Common questions about Heron Therapeutics
Heron Therapeutics (HRTX) has a market capitalization of $76.8M and trades on NASDAQ.
Heron Therapeutics has approximately 126 employees.